Citations (71)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Marilyn N Bulloch. (2023) Treatment and prevention of influenza in geriatric patients. Expert Review of Clinical Pharmacology 16:9, pages 825-841.
Read now
Read now
Jinshen Wang, Yihang Sun & Shuwen Liu. (2022) Emerging antiviral therapies and drugs for the treatment of influenza. Expert Opinion on Emerging Drugs 27:4, pages 389-403.
Read now
Read now
Anjali Sharma, Smritilekha Bera & Dhananjoy Mondal. (2022) Advances in the synthesis of antiviral agents from carbohydrate-derived chiral pools. Journal of Carbohydrate Chemistry 41:7-9, pages 424-510.
Read now
Read now
V.K. Tran-Nguyen, M.T. Le, T.D. Tran, V.D. Truong & K.M. Thai. (2019) Peramivir binding affinity with influenza A neuraminidase and research on its mutations using an induced-fit docking approach. SAR and QSAR in Environmental Research 30:12, pages 899-917.
Read now
Read now
Matteo Bassetti, Nadia Castaldo & Alessia Carnelutti. (2019) Neuraminidase inhibitors as a strategy for influenza treatment: pros, cons and future perspectives. Expert Opinion on Pharmacotherapy 20:14, pages 1711-1718.
Read now
Read now
Susanna Esposito & Nicola Principi. (2016) Oseltamivir for influenza infection in children: risks and benefits. Expert Review of Respiratory Medicine 10:1, pages 79-87.
Read now
Read now
Articles from other publishers (65)
Ha T. Nguyen, Anton Chesnokov, Juan De La Cruz, Philippe Noriel Q. Pascua, Vasiliy P. Mishin, Yunho Jang, Joyce Jones, Han Di, Andrei A. Ivashchenko, Mary Lea Killian, Mia K. Torchetti, Kristina Lantz, David E. Wentworth, Charles T. Davis, Alexandre V. Ivachtchenko & Larisa V. Gubareva. (2023) Antiviral susceptibility of clade 2.3.4.4b highly pathogenic avian influenza A(H5N1) viruses isolated from birds and mammals in the United States, 2022. Antiviral Research 217, pages 105679.
Crossref
Crossref
Junhao Luo, Zhuohan Zhang, Song Zhao & Rongbao Gao. (2023) A Comparison of Etiology, Pathogenesis, Vaccinal and Antiviral Drug Development between Influenza and COVID-19. International Journal of Molecular Sciences 24:7, pages 6369.
Crossref
Crossref
Sania Batool, Santosh Chokkakula & Min-Suk Song. (2023) Influenza Treatment: Limitations of Antiviral Therapy and Advantages of Drug Combination Therapy. Microorganisms 11:1, pages 183.
Crossref
Crossref
Han Ju, Lingxin Hou, Fabao Zhao, Ying Zhang, Ruifang Jia, Laura Guizzo, Anna Bonomini, Jiwei Zhang, Zhen Gao, Ruipeng Liang, Chiara Bertagnin, Xiujie Kong, Xiuli Ma, Dongwei Kang, Arianna Loregian, Bing Huang, Xinyong Liu & Peng Zhan. (2022)
Iterative Optimization and Structure–Activity Relationship Studies of Oseltamivir Amino Derivatives as Potent and Selective Neuraminidase Inhibitors
via
Targeting 150-Cavity
. Journal of Medicinal Chemistry 65:17, pages 11550-11573.
Crossref
Crossref
Shahab Mahmoudvand, Razieh Amini, Farid Azizi Jalilian, Mojtaba Hedayat Yaghoobi, Masoumeh Javaheri, Iraj Sedighi, Mojgan Mamani, Razieh Ezati, Jalaledin Amiri & Massoud Saidijam. (2022) Determination of Oseltamivir Resistance Level by an H275Y Genotyping Assay among Influenza A (H1N1) Viruses in Hamadan Province, Iran. journal of ilam university of medical sciences 30:3, pages 55-61.
Crossref
Crossref
Kai Ji, Guo-Ning Zhang, Jian-Yuan Zhao, Mei Zhu, Ming-Hua Wang, Ju-Xian Wang, Shan Cen, Yu-Cheng Wang & Wen-Yan Li. (2022) Design, synthesis, and anti-influenza A virus activity evaluation of novel indole containing derivatives of triazole. Bioorganic & Medicinal Chemistry Letters 64, pages 128681.
Crossref
Crossref
Magdalena Świerczyńska, Dagmara M. Mirowska-Guzel & Edyta Pindelska. (2022) Antiviral Drugs in Influenza. International Journal of Environmental Research and Public Health 19:5, pages 3018.
Crossref
Crossref
Chuanqi Duan, Weiyuan Liu, Siju Bi, Liang Chen, Jing Pan, Ting Zhou, Kuaile Lin & Weicheng Zhou. (2021)
Synthesis and characterization of 4(
R
)‐epimer impurities of zanamivir and laninamivir octanoate
. Journal of Heterocyclic Chemistry 59:3, pages 569-576.
Crossref
Crossref
Danial Sedighpour & Hadi Taghizadeh. (2022) The effects of mutation on the drug binding affinity of Neuraminidase: case study of Capsaicin using steered molecular dynamics simulation. Journal of Molecular Modeling 28:2.
Crossref
Crossref
Sandra Anderson, Paul Atkins, Per Bäckman, David Cipolla, Andrew Clark, Evangelia Daviskas, Bernd Disse, Plamena Entcheva-Dimitrov, Rick Fuller, Igor Gonda, Hans Lundbäck, Bo Olsson & Jeffry Weers. (2022) Inhaled Medicines: Past, Present, and Future. Pharmacological Reviews 74:1, pages 48-118.
Crossref
Crossref
Larisa Gubareva & Teena Mohan. (2022) Antivirals Targeting the Neuraminidase. Cold Spring Harbor Perspectives in Medicine 12:1, pages a038455.
Crossref
Crossref
S.K. Katiyar, S.N. Gaur, R.N. Solanki, Nikhil Sarangdhar, J.C. Suri, Raj Kumar, G.C. Khilnani, Dhruva Chaudhary, Rupak Singla, Parvaiz A. Koul, Ashok A. Mahashur, A.G. Ghoshal, D. Behera, D.J. Christopher, Deepak Talwar, Dhiman Ganguly, H. Paramesh, K.B. Gupta, Mohan Kumar T, P.D. Motiani, P.S. Shankar, Rajesh Chawla, Randeep Guleria, S.K. Jindal, S.K. Luhadia, V.K. Arora, V.K. Vijayan, Abhishek Faye, Aditya Jindal, Amit K. Murar, Anand Jaiswal, Arunachalam M, A.K. Janmeja, Brijesh Prajapat, C. Ravindran, Debajyoti Bhattacharyya, George D'Souza, Inderpaul Singh Sehgal, J.K. Samaria, Jogesh Sarma, Lalit Singh, M.K. Sen, Mahendra K. Bainara, Mansi Gupta, Nilkanth T. Awad, Narayan Mishra, Naveed N. Shah, Neetu Jain, Prasanta R. Mohapatra, Parul Mrigpuri, Pawan Tiwari, R. Narasimhan, R. Vijai Kumar, Rajendra Prasad, Rajesh Swarnakar, Rakesh K. Chawla, Rohit Kumar, S. Chakrabarti, Sandeep Katiyar, Saurabh Mittal, Sonam Spalgais, Subhadeep Saha, Surya Kant, V.K. Singh, Vijay Hadda, Vikas Kumar, Virendra Singh, Vishal Chopra & Visweswaran B. (2022) Indian Guidelines on Nebulization Therapy. Indian Journal of Tuberculosis 69, pages S1-S191.
Crossref
Crossref
Emanuele Palomba, Valeria Castelli, Giulia Renisi, Alessandra Bandera, Andrea Lombardi & Andrea Gori. (2021) Antiviral Treatments for Influenza. Seminars in Respiratory and Critical Care Medicine 42:06, pages 859-872.
Crossref
Crossref
Rueshandra Roosenhoff, Martin Schutten, Vaughan Reed, Barry Clinch, Anne van der Linden, Ron A.M. Fouchier & Pieter L.A. Fraaij. (2021) Secondary substitutions in the hemagglutinin and neuraminidase genes associated with neuraminidase inhibitor resistance are rare in the Influenza Resistance Information Study (IRIS). Antiviral Research 189, pages 105060.
Crossref
Crossref
Yaqin Bai, Jeremy C. Jones, Sook-San Wong & Mark Zanin. (2021) Antivirals Targeting the Surface Glycoproteins of Influenza Virus: Mechanisms of Action and Resistance. Viruses 13:4, pages 624.
Crossref
Crossref
Lu Lu, Shan Su, Haitao Yang & Shibo Jiang. (2021) Antivirals with common targets against highly pathogenic viruses. Cell 184:6, pages 1604-1620.
Crossref
Crossref
Sjoerd Slagman & Wolf-Dieter Fessner. (2021) Biocatalytic routes to anti-viral agents and their synthetic intermediates. Chemical Society Reviews 50:3, pages 1968-2009.
Crossref
Crossref
Sphamadla E. Mtambo, Daniel G. Amoako, Anou M. Somboro, Clement Agoni, Monsurat M. Lawal, Nelisiwe S. Gumede, Rene B. Khan & Hezekiel M. Kumalo. (2021) Influenza Viruses: Harnessing the Crucial Role of the M2 Ion-Channel and Neuraminidase toward Inhibitor Design. Molecules 26:4, pages 880.
Crossref
Crossref
Bruno Lina. 2021. Encyclopedia of Virology. Encyclopedia of Virology
160
174
.
Simone E. Adams, Vladimir Y. Lugovtsev, Anastasia Kan, Nicolai V. Bovin, Raymond P. Donnelly & Natalia A. Ilyushina. (2020) Laninamivir-Interferon Lambda 1 Combination Treatment Promotes Resistance by Influenza A Virus More Rapidly than Laninamivir Alone. Antimicrobial Agents and Chemotherapy 64:7.
Crossref
Crossref
Rubaiyea Farrukee, Celeste Ming-Kay Tai, Ding Yuan Oh, Danielle E. Anderson, Vithiagaran Gunalan, Martin Hibberd, Gary Yuk-Fai Lau, Ian G. Barr, Veronika von Messling, Sebastian Maurer-Stroh & Aeron C. Hurt. (2020) Utilising animal models to evaluate oseltamivir efficacy against influenza A and B viruses with reduced in vitro susceptibility. PLOS Pathogens 16:6, pages e1008592.
Crossref
Crossref
Yasuharu Okamoto. (2020) Finding a Maximum Common Subgraph from Molecular Structural Formulas through the Maximum Clique Approach Combined with the Ising Model. ACS Omega 5:22, pages 13064-13068.
Crossref
Crossref
Jiun-Jie Shie & Jim-Min Fang. (2019) Development of effective anti-influenza drugs: congeners and conjugates – a review. Journal of Biomedical Science 26:1.
Crossref
Crossref
Xiujuan Zhao, Yanyan Wang, Qinghua Cui, Ping Li, Lin Wang, Zinuo Chen, Lijun Rong & Ruikun Du. (2019) A Parallel Phenotypic Versus Target-Based Screening Strategy for RNA-Dependent RNA Polymerase Inhibitors of the Influenza A Virus. Viruses 11:9, pages 826.
Crossref
Crossref
Li Ping Cheng, Tian Chi Wang, Rao Yu, Meng Li & Jin Wen Huang. (2018) Design, synthesis and biological evaluation of novel zanamivir derivatives as potent neuraminidase inhibitors. Bioorganic & Medicinal Chemistry Letters 28:23-24, pages 3622-3629.
Crossref
Crossref
Anna Luganini, Maria E. Terlizzi, Gianluca Catucci, Gianfranco Gilardi, Massimo E. Maffei & Giorgio Gribaudo. (2018) The Cranberry Extract Oximacro® Exerts in vitro Virucidal Activity Against Influenza Virus by Interfering With Hemagglutinin. Frontiers in Microbiology 9.
Crossref
Crossref
Ding Yuan Oh, Jacqueline Panozzo, Sophie Vitesnik, Rubaiyea Farrukee, David Piedrafita, Jennifer Mosse & Aeron C Hurt. (2017) Selection of Multi-Drug Resistant Influenza A and B Viruses under Zanamivir Pressure and their Replication Fitness in Ferrets. Antiviral Therapy 23:4, pages 295-306.
Crossref
Crossref
Zhongxia Zhou, Tao Liu, Jian Zhang, Peng Zhan & Xinyong Liu. (2018) Influenza A virus polymerase: an attractive target for next-generation anti-influenza therapeutics. Drug Discovery Today 23:3, pages 503-518.
Crossref
Crossref
Toshiki Murasaka, Kenji Ikemura, Tomoyuki Enokiya, Yuichi Muraki, Mayumi Ikemura, Koji Terada, Takuya Iwamoto & Masahiro Okuda. (2017) Impact of the number of repeated inhalations and patient characteristics on the residual amount of inhaled laninamivir octanoate hydrate dry powder in pediatric patients with influenza. Journal of Pharmaceutical Health Care and Sciences 3:1.
Crossref
Crossref
Megan L. Shaw. (2017) The Next Wave of Influenza Drugs. ACS Infectious Diseases 3:10, pages 691-694.
Crossref
Crossref
Rubaiyea Farrukee & Aeron C. Hurt. (2017) Antiviral Drugs for the Treatment and Prevention of Influenza. Current Treatment Options in Infectious Diseases 9:3, pages 318-332.
Crossref
Crossref
K.L. Powell, E. Thomas & G.S. Cockerill. 2017. Comprehensive Medicinal Chemistry III. Comprehensive Medicinal Chemistry III
665
681
.
Maywan Hariono, Nurshariza Abdullah, K.V. Damodaran, Ezatul E. Kamarulzaman, Nornisah Mohamed, Sharifah Syed Hassan, Shaharum Shamsuddin & Habibah A. Wahab. (2016) Potential New H1N1 Neuraminidase Inhibitors from Ferulic Acid and Vanillin: Molecular Modelling, Synthesis and in Vitro Assay. Scientific Reports 6:1.
Crossref
Crossref
Flor M. Munoz & Henry H. Bernstein. (2016) Influenza Prophylaxis in Children: Could a Single Dose of One Drug Be an Option?. Pediatrics 138:6.
Crossref
Crossref
Pedro Laborda, Su-Yan Wang & Josef Voglmeir. (2016) Influenza Neuraminidase Inhibitors: Synthetic Approaches, Derivatives and Biological Activity. Molecules 21:11, pages 1513.
Crossref
Crossref
Serena Massari, Laura Goracci, Jenny Desantis & Oriana Tabarrini. (2016) Polymerase Acidic Protein–Basic Protein 1 (PA–PB1) Protein–Protein Interaction as a Target for Next-Generation Anti-influenza Therapeutics. Journal of Medicinal Chemistry 59:17, pages 7699-7718.
Crossref
Crossref
Long-Zhi Lin & Jim-Min Fang. (2016) Total Synthesis of Anti-Influenza Agents Zanamivir and Zanaphosphor via Asymmetric Aza-Henry Reaction. Organic Letters 18:17, pages 4400-4403.
Crossref
Crossref
Sudhir Venkatesan, Rebecca J. Cox, Jonathan S. Nguyen-Van-Tam & Puja R. Myles. 2016. SARS, MERS and other Viral Lung Infections. SARS, MERS and other Viral Lung Infections
35
64
.
Bipin Vaidya, Se-Young Cho, Kyung-Seo Oh, Song Hak Kim, Yeong O Kim, Eun-Hye Jeong, Thoa Thi Nguyen, Sung Hyun Kim, In Seon Kim, Joseph Kwon & Duwoon Kim. (2016) Effectiveness of Periodic Treatment of Quercetin against Influenza A Virus H1N1 through Modulation of Protein Expression. Journal of Agricultural and Food Chemistry 64:21, pages 4416-4425.
Crossref
Crossref
Justyna Ciejka, Aleksandra Milewska, Magdalena Wytrwal, Jacek Wojarski, Anna Golda, Marek Ochman, Maria Nowakowska, Krzysztof Szczubialka & Krzysztof Pyrc. (2016) Novel Polyanions Inhibiting Replication of Influenza Viruses. Antimicrobial Agents and Chemotherapy 60:4, pages 1955-1966.
Crossref
Crossref
Ding Y. Oh & Aeron C. Hurt. (2016) Using the Ferret as an Animal Model for Investigating Influenza Antiviral Effectiveness. Frontiers in Microbiology 7.
Crossref
Crossref
Tuba Incecayir, Jing Sun, Yasuhiro Tsume, Hao Xu, Tomoka Gose, Takeo Nakanishi, Ikumi Tamai, John Hilfinger, Elke Lipka & Gordon L. Amidon. (2016) Carrier-Mediated Prodrug Uptake to Improve the Oral Bioavailability of Polar Drugs: An Application to an Oseltamivir Analogue. Journal of Pharmaceutical Sciences 105:2, pages 925-934.
Crossref
Crossref
Hiroki Kondo, Yugo Shobugawa, Akinobu Hibino, Ren Yagami, Clyde Dapat, Minoru Okazaki, Taketo Otsuka, Koyata Fujii, Mohd Rohaizat Hassan & Reiko Saito. (2016) Influenza Virus Shedding in Laninamivir-Treated Children upon Returning to School. The Tohoku Journal of Experimental Medicine 238:2, pages 113-121.
Crossref
Crossref
Jacqueline Panozzo, Ding Yuan Oh, Kenneth Margo, David A. Morton, David Piedrafita, Jennifer Mosse & Aeron C. Hurt. (2015) Evaluation of a dry powder delivery system for laninamivir in a ferret model of influenza infection. Antiviral Research 120, pages 66-71.
Crossref
Crossref
Roberto Gasparini, Piero Luigi Lai, Francesca Casabona, Cecilia Trucchi, Sara Boccalini, Maria Luisa Cristina, Stefania Rossi, Daniela Amicizia & Donatella Panatto. (2014) Do the omeprazole family compounds exert a protective effect against influenza-like illness?. BMC Infectious Diseases 14:1.
Crossref
Crossref
Aeron C Hurt. (2014) The epidemiology and spread of drug resistant human influenza viruses. Current Opinion in Virology 8, pages 22-29.
Crossref
Crossref
Robert G. Webster & Elena A. Govorkova. (2014) Continuing challenges in influenza. Annals of the New York Academy of Sciences 1323:1, pages 115-139.
Crossref
Crossref
Qi (Tony) Zhou, Patricia Tang, Sharon Shui Yee Leung, John Gar Yan Chan & Hak-Kim Chan. (2014) Emerging inhalation aerosol devices and strategies: Where are we headed?. Advanced Drug Delivery Reviews 75, pages 3-17.
Crossref
Crossref
Wander Van Breedam, Stefan Pöhlmann, Herman W. Favoreel, Raoul J. de Groot & Hans J. Nauwynck. (2014) Bitter-sweet symphony: glycan–lectin interactions in virus biology. FEMS Microbiology Reviews 38:4, pages 598-632.
Crossref
Crossref
Chun-Lin Chen, Tzu-Chen Lin, Shi-Yun Wang, Jiun-Jie Shie, Keng-Chang Tsai, Yih-Shyun E. Cheng, Jia-Tsrong Jan, Chun-Jung Lin, Jim-Min Fang & Chi-Huey Wong. (2014) Tamiphosphor monoesters as effective anti-influenza agents. European Journal of Medicinal Chemistry 81, pages 106-118.
Crossref
Crossref
Chung-Kai Cheng, Chen-Hsuan Tsai, Jiun-Jie Shie & Jim-Min Fang. (2014) From neuraminidase inhibitors to conjugates: a step towards better anti-influenza drugs?. Future Medicinal Chemistry 6:7, pages 757-774.
Crossref
Crossref
Hideyuki Ikematsu, Naoki Kawai, Norio Iwaki & Seizaburo Kashiwagi. (2014) The duration of fever and other symptoms after the initiation of laninamivir octanoate hydrate in the Japanese 2011–2012 influenza season. Journal of Infection and Chemotherapy 20:2, pages 81-85.
Crossref
Crossref
Sanjay Kapoor & Kuldeep DhamaSanjay Kapoor & Kuldeep Dhama. 2014. Insight into Influenza Viruses of Animals and Humans. Insight into Influenza Viruses of Animals and Humans
163
216
.
Jiun-Jie Shie & Jim-Min Fang. (2014) Phosphonate Congeners of Oseltamivir and Zanamivir as Effective Anti-influenza Drugs: Design, Synthesis and Biological Activity. Journal of the Chinese Chemical Society 61:1, pages 127-141.
Crossref
Crossref
Guy Boivin. (2013) Detection and management of antiviral resistance for influenza viruses. Influenza and Other Respiratory Viruses 7, pages 18-23.
Crossref
Crossref
Naoki Kawai, Hideyuki Ikematsu, Takashi Kawashima, Tetsunari Maeda, Hiroshi Ukai, Nobuo Hirotsu, Norio Iwaki & Seizaburo Kashiwagi. (2013) Increased symptom severity but unchanged neuraminidase inhibitor effectiveness for A(H1N1)pdm09 in the 2010-2011 season: comparison with the previous season and with seasonal A(H3N2) and B. Influenza and Other Respiratory Viruses 7:3, pages 448-455.
Crossref
Crossref
Mélanie Samson, Andrés Pizzorno, Yacine Abed & Guy Boivin. (2013) Influenza virus resistance to neuraminidase inhibitors. Antiviral Research 98:2, pages 174-185.
Crossref
Crossref
Nicholas A. Meanwell, Stanley V. D'Andrea, Christopher W. Cianci, Ira B. Dicker, Kap‐Sun Yeung, Makonen Belema & Mark Krystal. 2013. Drug Discovery. Drug Discovery
439
515
.
Chih-An Chen & Jim-Min Fang. (2013) Synthesis of oseltamivir and tamiphosphor from N-acetyl-d-glucosamine. Organic & Biomolecular Chemistry 11:44, pages 7687.
Crossref
Crossref
Sailen Barik. (2012) New treatments for influenza. BMC Medicine 10:1.
Crossref
Crossref
Suki Man-Yan Lee & Hui-Ling Yen. (2012) Targeting the host or the virus: Current and novel concepts for antiviral approaches against influenza virus infection. Antiviral Research 96:3, pages 391-404.
Crossref
Crossref
Ting-Jen R. Cheng, Steven Weinheimer, E. Bart Tarbet, Jia-Tsrong Jan, Yih-Shyun E. Cheng, Jiun-Jie Shie, Chun-Lin Chen, Chih-An Chen, Wei-Che Hsieh, Pei-Wei Huang, Wen-Hao Lin, Shi-Yun Wang, Jim-Min Fang, Oliver Yoa-Pu Hu & Chi-Huey Wong. (2012) Development of Oseltamivir Phosphonate Congeners as Anti-influenza Agents. Journal of Medicinal Chemistry 55:20, pages 8657-8670.
Crossref
Crossref
Enguang Feng, Deju Ye, Jian Li, Dengyou Zhang, Jinfang Wang, Fei Zhao, Rolf Hilgenfeld, Mingyue Zheng, Hualiang Jiang & Hong Liu. (2012) Recent Advances in Neuraminidase Inhibitor Development as Anti-influenza Drugs. ChemMedChem 7:9, pages 1527-1536.
Crossref
Crossref
Donald F Smee, Brett L Hurst & Craig W Day. (2012)
D282, a Non-Nucleoside Inhibitor of Influenza Virus Infection that Interferes with
de novo
Pyrimidine Biosynthesis
. Antiviral Chemistry and Chemotherapy 22:6, pages 263-272.
Crossref
Crossref
Sehee ParkJin Il KimMan-Seong Park. (2012) Antiviral Agents Against Influenza Viruses. Journal of Bacteriology and Virology 42:4, pages 284.
Crossref
Crossref